Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 31, 2015
Pharmacy Choice - Pharmacy News - January 31, 2015

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
1/31/15 - Shire Says FDA Approves Vyvanse To Treat Binge Eating Disorder
SAINT HELIER- Shire plc said Friday that the U.S. Food and Drug Administration has approved Vyvanse Capsules, the first and only medication for the treatment of moderate to severe binge eating disorder in adults, shown to significantly reduce the mean number of binge days per week. Vyvanse is not indicated or recommended for weight loss or the trea
1/31/15 - United States : FDA expands approved use of Imbruvica for rare form of non-Hodgkin lymphoma [TendersInfo (India)]
Today s approval highlights the importance of development of drugs for supplemental indications, said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA s Center for Drug Evaluation and Research. The FDA initially granted Imbruvica accelerated approval in November 2013 for use in patients with mantle cell ly
1/31/15 - Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder
--Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse ® Capsules, the first and only medication for the treatment of moderate to severe binge eating disorder in adults, shown to significantly reduce the mean number of binge days per week. "Binge eating disorder is the most common adult eating disorder in the Unit
1/31/15 - Zogenix Receives FDA Approval of New Formulation of Zohydro(R) ER
--Zogenix, Inc., a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders, today announced that the U.S. Food and Drug Administration has approved a new formulation of Zohydro ® ER Extended-Release Capsules, CII, with BeadTek�. Concurrently, Zogenix has ongoing Human Abuse Liability s
1/30/15 - Bristol-Myers' Evotaz gets FDA approval for HIV-1 treatment in adults [EMBIN (Emerging Markets Business Information News]
The US Food and Drug Administration has approved Bristol-Myers Squibb's Evotaz tablets in combination with other antiretroviral agents to treat HIV-1 infection in adults. The once-daily Evotaz is a combination of the protease inhibitor atazanavir, marketed as Reyataz capsules, and cobicistat, a pharmacokinetic enhancer marketed by Gilead Sciences.
1/30/15 - FDA approves ADHD drug for binge-eating disorder
WASHINGTONâ?? Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder. About 2 percent of U.S. adults, or about 5 million people, have binge eating disorder, according to the Department of Health and Human Services. The Food and Drug Administration originally

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Drug Therapy Management Series Part I: Cardiovascular Disorders
This lesson is supported by:
RxSchool
Workplace Safety & Joint Commission Standards for Pharmacy Professionals
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415